JoVE Logo
Faculty Resource Center

Sign In

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

DOI :

10.3791/54393-v

September 30th, 2016

September 30th, 2016

13,196 Views

1Medicine, University of Colorado Denver Anschutz Medical Campus

Utilizing patient-derived tumors in a subcutaneous preclinical model is an excellent way to study the efficacy of novel therapies, predictive biomarker discovery, and drug resistant pathways. This model, in the drug development process, is essential in determining the fate of many novel anti-cancer therapies prior to clinical investigation.

Tags

Patient Derived Tumor Xenograft

-- Views

Related Videos

article

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

article

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

article

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

article

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

article

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

article

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

article

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

article

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

article

A Melanoma Patient-Derived Xenograft Model

article

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved